Founded in 2006, Cyagen is a global provider of genetically modified lung models and innovative cell and gene therapy solutions for research and development (P&D), notably: o development of doenças models, AAV discovery, the studies of medical efficiency, and much more. Cyagen currently has more than 900 staff and facilities totaling more than 40,000 square meters, encompassing our American social network in Santa Clara, California, and elsewhere in Japan and China. From a strong foundation in the development of animated models to the implementation of artificial intelligence (AI)-based tools for data analysis and therapeutic discovery, Cyagen provides unique solutions to accelerate fundamental research and P&D of new drugs thanks to our exclusive offer. . of models, dice, algorithms and services.

Exclusive solutions for all the necessary research models.

Our services complete the entire model generation process: from the conception of a transgenic/genetic breeding strategy, through model development, selection, cryopreservation and phenotypic analysis. Our CRO service platforms need everything you need for drug discovery and preclinical research to understand specialized cell and gene therapy (CGT) therapeutic domains such as ophthalmology, immuno-oncology, and neurosciences.

cyagen bioscience
cyagen bioscience

Do you want to work with Cyagen?

  • More than 15 years of experience in animal genetic modification and management of personalized models.
  • He works with more than 3,000 life science institutions in the world.
  • More than 50,000 models of souris e rats with temporary delivery
  • More than 6,200 citations in SCI journals